Singapore vs Togo: Cases started on MDR-TB treatment
Singapore
22
in 2024
Togo
21
in 2024
Singapore rank
104th
Togo rank
105th
Cases started on MDR-TB treatment over time
- Singapore
- Togo
How they compare
Singapore currently reports 22 against 21 in Togo, a difference of 1.
The two have swapped places 4 times across 17 shared years of data; in 2008 it was Singapore ahead.
Singapore ranks 104th and Togo ranks 105th of 193 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5 | 0.5 | 3 | Singapore |
| 2010s | 13.6 | 9 | 4.6 | Singapore |
| 2020s | 19.4 | 16.6 | 2.8 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Singapore or Togo?
- Singapore, at 22 against 21 in Togo as of 2024.
- What is the difference in cases started on mdr-tb treatment between Singapore and Togo?
- 1, with Singapore ahead.
- How many years of comparable data are there for Singapore and Togo?
- 17 years are reported by both, from 2008 to 2024.
- How do Singapore and Togo rank globally for cases started on mdr-tb treatment?
- Singapore ranks 104th and Togo ranks 105th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.